From the *University of Rochester, Rochester, New York; the †Dana Farber Cancer Institute, Boston, Massachusetts; ‡Baylor College of Medicine, Houston, Texas; the §University of Pretoria, Pretoria, South Africa; and the ∥University of Colorado, Denver, Colorado.
This study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, MD, Chair) and supported in part by Public Health Service grants CA11083, CA23318, CA22433, CA32102, CA16116, CA66636, CA21115 and from the National Cancer Institute, National Institutes of Health, and the Department of Health and Human Services. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.
This study was presented in part at the 31st annual meeting of ASCO, May 1995.
Reprints: Kishan J. Pandya, MD, University of Rochester, James P. Wilmot Cancer Center, 601 Elmwood Avenue, Box 704, Rochester, NY 14642. E-mail: [email protected].
